My Thoughts On Arrayit Situation
I know many of you are curious on what goes with ARYC and why the financials have not been published. I am in the same position and those of you reading the IHUB will get all kinds of ideas from the crazy posters on the HUB. Let me state a few facts and we can go from there.
1.ARYC has been in business for over 25 years and has designed and delivered millions of dollars of analytic equipment unmatched in the World. Their equipment is being used by some of most demanding, prestigious organizations in the world with unequaled performance. FDA, VA, Dept of Agriculture and 2 other organizations used their devices with 100% accuracy. One was just announced today in a release by CEO Rene that was the 5th one that reached 100% accuracy in their allergy testing. A phenomenal record and unheard of in the field of measurement.
2. Their sales for the last several months at $2million dollars /week. With a staff of 15 and a building of 15,000 sq ft and the margin of profit of the blood cards you can rest assure financing and cash flow is not a problem. The projected sales might easily be double of the current rate.
3.A recent post #141272, by Stock Detective on 5/18/19 is a phenomenal list of organizations who will provide services that will list services unheard of in the field of allergy testing and guess who will supply the equipment for those services. This links Arrayit to a huge proprietary market and unchallenged by any other competitor. You can click each one of these and view that company and what they do utilizing Arrayit devices. It is difficult to imagine the amount of revenue that will pour into Arrayit with all these companies performing these blood tests. View a few of them and it is easily seen that there will be a tremendous influx of business for Arrayit in a short time and increase sales dramatically’
4.Arrayit’s announced goal is to be listed on NASDAQ as soon as possible. The requirements are to establish the value of the company along with certified financial statements. They have reported sales of $2m/week but for a short time and if they can be continued for another quarter it will have a tremendous impact on opening bid prices for the stock and the $4.00 open bid can be achieved. Can we fault management for attempting to achieve this goal?
.This is only my opinion and I believe it might even be much higher than $4 in a short time
